By GRETCHEN MORGENSON from NYT Business Day http://ift.tt/2aQ2psi
via IFTTTIt wasn’t just soaring drug prices that helped Valeant Pharmaceuticals’ cash flow. A credit for inventories at those higher prices also plumped the figures. July 31, 2016 at 05:00AM
No comments:
Post a Comment